Home » Authors » Nuala Moran

Articles by Nuala Moran

UK Creating Centers To Help Capitalize On Genetics Progress

Jan. 30, 2002

BIA Calls For More Support To Deal With Animal Rights Activists

Jan. 30, 2002

CAT Acquiring Canadian Firm Focused On Royalties For £55M

Jan. 23, 2002

Trigen Raises $10M, Looks To Take Drug Into Phase IIb Trials

Jan. 23, 2002

CXR Spun Out With £4M To Develop Products From Dundee

Jan. 23, 2002

CXR Spun Out With £4M To Develop Products From Dundee

Jan. 23, 2002

CAT Acquiring Canadian Firm Focused On Royalties For £55M

Jan. 23, 2002

Trigen Raises $10M, Looks To Take Drug Into Phase IIb Trials

Jan. 23, 2002

UK Group Calls For Safeguards Before DNA Database Creation

Jan. 16, 2002

Protesters Force Stephens Group To Sell Position In Huntingdon

Jan. 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...